Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA1/2 germline mutations in Jewish patients with uterine serous carcinoma.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society - 1 Oct 2010

Bruchim Ilan, Amichay Keren, Kidron Dvora, Attias Zohar, Biron-Shental Tal, Drucker Liat, Friedman Eitan, Werner Haim, Fishman Ami

Abstract excerpt

INTRODUCTION: Whether and to what extent germline mutations in the BRCA1 and BRCA2 genes increase the risk for developing uterine serous carcinoma (USC) remain controversial. We assessed the rate of the 3 predominant BRCA1/2 mutations in Jewish patients with USC and the relevance of carrier statu...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 Protein
Share to Chemotherapy, Adjuvant

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA1 Protein

Share to Cystadenocarcinoma, Serous

Share to Germ-Line Mutation

Share to Survival Rate

Share to Uterine Neoplasms

Source

Identifiers

PMID: 21206239
DOI: 10.1111/IGC.0b013e3181ef622d

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-21206239-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA1/2 germline mutations in Jewish patients with uterine serous carcinoma.PMID 21206239Read ↗

BRCA germline mutations in women with uterine serous carcinoma--still a debate.Semantic proximity Read ↗

BRCA germline mutations in Jewish women with uterine serous papillary carcinoma.Semantic proximity Read ↗

High incidence of BRCA1–2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinomaSemantic proximity Read ↗

BRCA1 germline mutations in women with uterine serous papillary carcinoma.Semantic proximity Read ↗

The rate of the predominant Jewish mutations in the BRCA1, BRCA2, MSH2 and MSH6 genes in unselected Jewish endometrial cancer patients.Semantic proximity Read ↗

Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers.Semantic proximity Read ↗

BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups.Semantic proximity Read ↗

Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.Semantic proximity Read ↗

Risk of endometrial carcinoma associated with BRCA mutation.Semantic proximity Read ↗

Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations.Semantic proximity Read ↗

A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer.Semantic proximity Read ↗

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.